Incyte incyte.com


Public lists: Pharma Startups (6570)

Incyte seeks to build a product pipeline of small molecule drugs.

Incyte seeks to build a product pipeline of small molecule drugs.

Company (Alive / Active)

Phone: 855-463-3463

Fax:

1801 Augustine Cut-off

Wilmington, 19803
Delaware, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Incyte $0M Mar 22, 2021
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Incyte Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

Competitors

Company Status Description Investors
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Bicyclic heterocycles as fgfr inhibitors Sep 10, 2019 Mar 16, 2021 Patent
Tricyclic heterocyclic compounds as sting activators May 24, 2019 Mar 16, 2021 Patent
Pyrazolopyridine compounds and uses thereof Aug 20, 2019 Mar 02, 2021 Patent
Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors Oct 04, 2019 Feb 16, 2021 Patent
Tricyclic heterocycles as bet protein inhibitors Sep 27, 2019 Feb 16, 2021 Patent
See all 479 patents